October 24, 2019 - Data from a phase 1, open-label, multi-center safety trial of lyophilized platelets were recently presented at the 2019 AABB Annual Meeting in San Antonio, Texas. Thrombosomes® (lyophilized platelets) are prepared from a pool of apheresis-derived human platelet units, pathogen-reduced with heat sterilization, and freeze-dried in the presence of trehalose (a naturally-derived simple sugar) and other small molecules which stabilize their structure until reconstruction.

Read More!